STIM
Neuronetics Inc (STIM)
Healthcare • NASDAQ • $1.66-10.05%
- Symbol
- STIM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $1.66
- Daily Change
- -10.05%
- Market Cap
- $115.17M
- Trailing P/E
- N/A
- Forward P/E
- -5.46
- 52W High
- $4.85
- 52W Low
- $0.80
- Analyst Target
- $4.33
- Dividend Yield
- N/A
- Beta
- 1.13
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Company websiteResearch STIM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.